Lung cancer remains one of the most prevalent and deadly forms of cancer worldwide. According to the World Health Organization (WHO), it is the leading cause of cancer deaths globally. The reality is that lung cancer often goes undetected until it reaches advanced stages, significantly reducing the chances of successful treatment and survival. Aspirus Iron River now shares hope on the horizon in the form of lung cancer screenings, which have proven to be effective in detecting the disease at its earliest and most treatable stages.
“I’ve witnessed firsthand the transformative impact of lung cancer screenings,” said Don Dumke, Supervisor - Imaging Services at Aspirus Health. “By utilizing advanced imaging technology, we have the power to detect abnormalities in the lungs at their earliest stages, often before symptoms manifest. These screenings not only save lives but also empower patients with knowledge and practice measures.”
Lung cancer screenings involve the use of low dose computed tomography (CT) scans to detect cancerous growths or abnormalities in the lungs. While lung cancer screenings are beneficial, they are typically recommended for individuals who are at a higher risk of developing the disease. Criteria for screening includes:
- Age 50-77 years.
- Current or former smoker (quit in the last 15 years).
- 20 pack-year history of smoking (packs per day x years smoked = pack years).
- Asymptomatic (no signs or symptoms of lung cancer, such as coughing blood).
- Have existing health conditions, such as chronic obstructive pulmonary disease (COPD), or a family history of lung cancer.
“The primary goal of lung cancer screenings is to detect the disease at its earliest stages when treatment options are most effective,” said John Pietila, MD, Radiologist at Aspirus Health. “Early detection through screening can improve survival rates among individuals diagnosed with lung cancer. By identifying cancer early, patients have a greater chance of successful treatment outcomes and a higher quality of life.”
Early detection can also reduce the need for aggressive and invasive treatment procedures such as surgery, chemotherapy, or radiation therapy. Instead, patients may have access to less invasive interventions, including targeted therapies, which can effectively target cancer cells.
“By providing these screenings locally, we’re not just detecting cancer earlier, we are also bringing advanced medical technologies to rural communities,” said Rae Kaare, Chief Administrative Officer for Aspirus Iron River Hospital & Clinics. “We will continue our commitment to bringing high quality care close to home.”
For more information on lung cancer screenings at Aspirus Iron River, call the central scheduling office at 715.847.2550 or visit aspirus.org.